»ï¼º¼¿ïº´¿ø ´ëÇѺñ´¢±âÁ¾¾çÇÐȸ-´ëÇÑÀü¸³¼±ÇÐȸ-ºñ´¢±â°è±âÃÊÀÇÇבּ¸È¸°øµ¿½ÉÆ÷Áö¾ö : 2019-01-19±³À°ÀÏÀÚ : 2019-01-19
±³À°Àå¼Ò : »ï¼º¼¿ïº´¿ø ¾Ïº´¿ø B1 ´ë°´ç
±³À°ÁÖÁ¦ :
´ëÇѺñ´¢±âÁ¾¾çÇÐȸ-´ëÇÑÀü¸³¼±ÇÐȸ-ºñ´¢±â°è±âÃÊÀÇÇבּ¸È¸°øµ¿½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇѺñ´¢±âÁ¾¾çÇÐȸ
´ã´çÀÚ : ±èÀºÁÖ
¿¬¶ôó : 02-704-8574
À̸ÞÀÏ :
app@app2010.com ±³À°Á¾·ù : ºñ´¢±â°ú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 20,000¿ø
ºñ°í »çÀüµî·Ï 2¸¸¿ø, ÇöÀåµî·Ï 3¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 01-19 08:30~08:50 Registration ()
±âŸ 01-19 08:50~09:00 Opening remark , Ãà»ç ()
±³À°½Ã°£ 01-19 09:00~09:20 Critical roles of hMAGEA2 in prostate cancer and development of cancer animal model ¹Ú¼Û(DGIST)
±³À°½Ã°£ 01-19 09:20~09:40 Identification of novel biomarkers for diagnosis of metastatic prostate cancer ÀÌ»ó±Ô(°æºÏ´ë ¾à´ë)
±³À°½Ã°£ 01-19 09:40~10:00 Expression of AR-V7 in urine derived exosomal RNA and development of CRPC ±¸ÀÚÀ±(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 01-19 10:00~10:20 Feasibility of ctDNA analysis in prostate cancer Á¶¿µ³²(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 01-19 10:20~10:40 ctDNA to predict prognosis of prostate cancer Á¶ÀºÇØ(³ì½ÊÀÚÁö³ð)
ÈÞ½Ä 01-19 10:40~11:00 Coffee break ()
±³À°½Ã°£ 01-19 11:00~11:20 Medical travel among non-Seoul residents to seek prostate cancer treatment in medical facilities of Seoul ±èÀçÇå(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 01-19 11:20~11:40 National practice patterns and medical costs for prostate cancer in Korea across a 10 year periods °È£¿ø(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 01-19 11:40~12:00 Lifestyle risk prediction model for prostate cancer in a Korean population ±è¼ºÇÑ(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 01-19 12:00~12:20 Surgical simulation in Urology °í¿µÈÖ(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 01-19 12:20~12:40 Digital health and future technology À̰Ǹí(ÃæºÏ´ëÇб³)
±âŸ 01-19 12:40~12:40 Closing remark ()